OTCM
FLMNY
Market cap4.05bUSD
Jul 02, Last price
9.94USD
Name
Fielmann AG
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Fielmann Aktiengesellschaft, together with its affiliated companies, specializes in both investing in and operating businesses within the optical and audiological sectors. The firm is responsible for the production and sale of a wide array of visual aids, including spectacles, frames, corrective lenses, sunglasses, contact lenses, and their associated accessories, along with various other general merchandise. Additionally, Fielmann provides hearing aids and their complementary accessories. By December 31, 2021, the company had established a significant retail presence, managing 693 stores across Europe. This extensive network comprised 610 outlets in Germany, 45 in Switzerland, 38 in Austria, 3 in Luxembourg, 43 in Italy, 37 in Poland, 87 in Spain, 32 in Slovenia, and an additional 15 locations spread throughout the rest of Europe. Furthermore, Fielmann operated 78 smaller retail points specifically in Eastern Europe. Beyond its physical stores, the company also makes its product selection available through online retail channels. Established in 1972 and based in Hamburg, Germany, Fielmann Aktiengesellschaft operates as a subsidiary under the ownership of Korva SE.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||